<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230726058935N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-08-27</date_registration>
      <primary_sponsor>Semnan University of Medical Sciences</primary_sponsor>
      <public_title>The effect of short-term solution-oriented treatment on depression, anxiety and Obsessive Compulsive Disorder</public_title>
      <acronym></acronym>
      <scientific_title>The effect of short-term solution-oriented treatment on depression, anxiety, and obsessive-compulsive disorder of entrance exam students compared to the control group</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-07-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71642</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Factorial, Purpose: Health service research, Randomization description: To select the research sample, the purposeful sampling method was used, so that among the 12th grade female students who were willing to participate in the research and through the interview with the researcher, anxiety, depression and mental obsession were observed in them. 15 people were selected as the experimental group and 15 people were selected as the control group. These people were matched into groups based on their parents' education and socio-economic status.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Depression. Condition 2: anxiety. Condition 3: Obsessive Compulsive Disorder.</hc_freetext>
      <i_freetext>Intervention 1: The first intervention group: the method of doing the work is that the experimental group receives short-term solution-oriented treatment every week for 60 minutes and for a duration of 8 weeks; The research community will be Semnan city entrance examination students. After selecting the subjects, it is time to randomly divide people into two control and intervention groups. After taking the pre-test, it is time to conduct the intervention. This intervention is carried out for 2 months on the experimental group, and after that, all 3 tests are taken again from both the experimental and control groups, the pre-test and post-test scores together. are compared The number of people in this group will be 15 people. A summary of the goals and treatment method, the first session: the communication of the group members with each other and with the leader, stating the basic framework; The second session: identifying the goals of the members, asking scaling questions and miracle questions; The third session: creating hope, participation, finding past and present exceptions; Session 4: Finding exceptions, crystal ball practice; The fifth session: discovering solutions, adaptive questioning; Sixth session: continuing to identify solutions, predictive task; Seventh session: reviewing and strengthening exceptions with the technique of repeating the same work; Session 8: Highlighting the changes that have happened, appreciating the efforts, closing. Intervention 2: The first control group: after selecting the subjects and conducting the necessary investigations to enter the research, it is now time to randomly divide people into two control and intervention groups. The control group will not receive any intervention, but after the intervention, the experimental group will be invited to answer all 3 questionnaires again. The pre-test and post-test scores of the two groups are compared. The number of people in this group will be 15 people.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Its release schedule is unknown</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Shiva Fuoladi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Second floor; Block 825; 4th Fatah Alley; Ettehad town; Varzesh boulevard, Nehzat street, Semnan</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3514973146</zip>
        <telephone>+98 23 3345 6463</telephone>
        <email>dr.shivafuoladi.psy@gmail.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Shiva Fuoladi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Second floor; Block 825; 4th Fatah Alley; Ettehad town; Varzesh boulevard, Nehzat street, Semnan</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3514973146</zip>
        <telephone>+98 23 3345 6463</telephone>
        <email>dr.shivafuoladi.psy@gmail.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having the age requirement of 18 years (12th educational year students)
Getting high marks in the questionnaire
Not receiving drug therapy or other psychotherapy
Conducting a clinical interview</inclusion_criteria>
      <agemin>17 years</agemin>
      <agemax>18 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Receiving drug therapy or other psychotherapy at the same time
Having mental disorders
Not getting the required grades in the questionnaires</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F32</hc_code>
      <hc_code>F41.1</hc_code>
      <hc_code>R46.81</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Major depressive disorder, single episode</hc_keyword>
      <hc_keyword>Generalized anxiety disorder</hc_keyword>
      <hc_keyword>Obsessive-compulsive behavior</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The first intervention group: the method of doing the work is that the experimental group receives short-term solution-oriented treatment every week for 60 minutes and for a duration of 8 weeks; The research community will be Semnan city entrance examination students. After selecting the subjects, it is time to randomly divide people into two control and intervention groups. After taking the pre-test, it is time to conduct the intervention. This intervention is carried out for 2 months on the experimental group, and after that, all 3 tests are taken again from both the experimental and control groups, the pre-test and post-test scores together. are compared The number of people in this group will be 15 people. A summary of the goals and treatment method, the first session: the communication of the group members with each other and with the leader, stating the basic framework; The second session: identifying the goals of the members, asking scaling questions and miracle questions; The third session: creating hope, participation, finding past and present exceptions; Session 4: Finding exceptions, crystal ball practice; The fifth session: discovering solutions, adaptive questioning; Sixth session: continuing to identify solutions, predictive task; Seventh session: reviewing and strengthening exceptions with the technique of repeating the same work; Session 8: Highlighting the changes that have happened, appreciating the efforts, closing.</i_keyword>
      <i_keyword>The first control group: after selecting the subjects and conducting the necessary investigations to enter the research, it is now time to randomly divide people into two control and intervention groups. The control group will not receive any intervention, but after the intervention, the experimental group will be invited to answer all 3 questionnaires again. The pre-test and post-test scores of the two groups are compared. The number of people in this group will be 15 people.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>High score in Beck Depression. Timepoint: before the beginning of therapeutic interventions in the first session, after the completion of the therapeutic intervention in the eighth session. Method of measurement: Beck depression questionnaire.</prim_outcome>
      <prim_outcome>High score in Beck Anxiety. Timepoint: before the beginning of therapeutic interventions in the first session, after the completion of the therapeutic intervention in the eighth session. Method of measurement: Beck anxiety questionnaire.</prim_outcome>
      <prim_outcome>High score in Madzely Obsession Questionnaire. Timepoint: before the beginning of therapeutic interventions in the first session, after the completion of the therapeutic intervention in the eighth session. Method of measurement: Madzely obsessive compulsive questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Semnan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-07-26</approval_date>
        <contact_name>Semnan branch; Islamic Azad University</contact_name>
        <contact_address>1st floor, Block 825, Fourth Fatah Alley, Etihad town, Varzesh Blvd, Nehzat street Semnan Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
